Privium Fund Management B.V.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 9, 2025), Privium Fund Management B.V. reported 56 stock positions worth $383.6 million. Its top holding was Spotify Technology (SPOT) at 21.0% of the portfolio, followed by Tesla (TSLA, 15.0%) and Shopify Class A (SHOP, 10.4%). Compared with Q4 2024, it opened 5 new positions, sold out of 8, added to 21 and reduced 13. The biggest buy was a new position in Springworks Therapeutics (SWTX) and the biggest sale an exit from Intra-Cellular Therapies (ITCI).
- Most Recent 13F
- Q2 2026
- Location
- AMSTERDAM, P7
- CIK
- 0001795097
- Portfolio Value
- $383.6M (Q1 2025)
- SEC Filing
- 0001754960-25-000288 ↗ filed May 9, 2025
Holdings Value
Holdings 56 stocks · $383.6M
| SPOT Spotify Technology SA | 20.98% | 145,000 | $80.5M | No change |
| TSLA Tesla Inc. | 14.96% | 220,000 | $57.4M | No change |
| SHOP Shopify Inc. Class A | 10.38% | 415,000 | $39.8M | No change |
| PLTR Palantir Technologies Inc. Class A | 7.98% | 360,000 | $30.6M | Reduce -2.7% |
| SE Sea Ltd.-ADR | 7.15% | 210,000 | $27.4M | No change |
| AMZN Amazon.com Inc. | 7.03% | 141,000 | $27.0M | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 2.36% | 249,804 | $9.0M | Reduce -3.3% |
| IONS Ionis Pharmaceuticals Inc. | 2.10% | 267,594 | $8.1M | Add +0.3% |
| ARWR Arrowhead Pharmaceuticals Inc. | 2.09% | 629,214 | $8.0M | Add +65.3% |
| NVDA Nvidia Corp. | 2.07% | 73,000 | $7.9M | No change |
| SNOW Snowflake Inc. | 1.86% | 48,000 | $7.1M | Reduce -36.0% |
| NET Cloudflare Inc. Class A | 1.76% | 60,000 | $6.8M | No change |
| PRQR Proqr Therapeutics NV | 1.73% | 4,985,633 | $6.6M | No change |
| AXSM Axsome Therapeutics Inc. | 1.60% | 52,732 | $6.2M | Reduce -15.3% |
| QURE Uniqure NV | 1.60% | 579,139 | $6.1M | Reduce -22.0% |
| SWTX Springworks Therapeutics Inc. | 1.43% | 123,980 | $5.5M | New |
| ARQT Arcutis Biotherapeutics Inc. | 1.33% | 325,709 | $5.1M | No change |
| ZLAB Zai Lab Ltd.-ADR | 1.25% | 132,189 | $4.8M | Reduce -28.6% |
| VRTX Vertex Pharmaceuticals Inc. | 1.05% | 8,300 | $4.0M | New |
| MRK Merck & Co. Inc. | 0.96% | 41,093 | $3.7M | Reduce -43.4% |
| RCKT Rocket Pharmaceuticals Inc. | 0.75% | 432,760 | $2.9M | Add +8.8% |
| ACAD Acadia Pharmaceuticals Inc. | 0.64% | 148,400 | $2.5M | No change |
| MRNA Moderna Inc. | 0.56% | 75,576 | $2.1M | Reduce -8.4% |
| CRSP Crispr Therapeutics AG | 0.53% | 60,097 | $2.0M | Add +71.7% |
| ABEV Ambev SA-ADR | 0.49% | 804,206 | $1.9M | Add +23.3% |
| CPNG Coupang Inc. | 0.48% | 81,900 | $1.8M | Reduce -42.3% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.40% | 5,716 | $1.5M | New |
| KRYS Krystal Biotech Inc. | 0.35% | 7,510 | $1.4M | Reduce -18.8% |
| ROIV Roivant Sciences Ltd. | 0.33% | 126,923 | $1.3M | Reduce -41.1% |
| IMVT Immunovant Inc. | 0.32% | 72,000 | $1.2M | New |
| URGN Urogen Pharma Ltd. | 0.31% | 107,622 | $1.2M | Add +288.6% |
| RNAM Avidity Biosciences Inc. | 0.27% | 34,500 | $1.0M | Add +8.2% |
| WVE Wave Life Sciences Ltd. | 0.24% | 113,550 | $917K | Add +29.0% |
| PFE Pfizer Inc. | 0.21% | 32,327 | $819K | Add +47.1% |
| VAL Valaris Ltd. | 0.21% | 20,222 | $794K | Add +42.6% |
| MGTX Meiragtx Holdings PLC | 0.21% | 117,000 | $793K | Reduce -48.0% |
| NOV Nov Inc. | 0.20% | 49,745 | $757K | Add +16.0% |
| RXRX Recursion Pharmaceuticals-A | 0.16% | 119,000 | $630K | No change |
| AIG American International Group | 0.15% | 6,483 | $564K | Reduce -19.2% |
| LXEO Lexeo Therapeutics Inc. | 0.14% | 160,198 | $556K | Add +16.0% |
| PAAS Pan American Silver Corp. | 0.14% | 21,284 | $550K | No change |
| SA Seabridge Gold Inc. | 0.13% | 44,074 | $514K | Add +22.5% |
| EMX Emx Royalty Corp. filed as EMX RTY CORP | 0.12% | 216,968 | $443K | No change |
| VZLA Vizsla Silver Corp. | 0.11% | 192,487 | $437K | Add +65.2% |
| FDMT 4D Molecular Therapeutics Inc. | 0.11% | 131,000 | $423K | Add +8.3% |
| NTLA Intellia Therapeutics Inc. | 0.11% | 58,709 | $417K | Add +111.9% |
| URNM Sprott Uranium Miners ETF | 0.10% | 12,114 | $393K | Add +17.9% |
| AUTL Autolus Therapeutics PLC | 0.10% | 251,674 | $390K | Add +8.6% |
| NE Noble Corp. PLC | 0.09% | 14,287 | $339K | Add +35.7% |
| ALXO Alx Oncology Holdings Inc. | 0.08% | 509,059 | $317K | No change |
| DYN Dyne Therapeutics Inc. | 0.08% | 27,566 | $288K | Add +35.4% |
| SD Sandridge Energy Inc. | 0.07% | 23,300 | $266K | No change |
| TSHA Taysha Gene Therapies Inc. | 0.05% | 134,900 | $188K | No change |
| SBSW Sibanye-Stillwater Ltd.-ADR | 0.04% | 34,040 | $156K | No change |
| FATE Fate Therapeutics Inc. | 0.02% | 109,026 | $86K | Add +25.3% |
| VYGR Voyager Therapeutics Inc. | 0.02% | 21,645 | $73K | New |
Portfolio Sells Q4 2024 → Q1 2025
| ITCI Intra-Cellular Therapies Inc. | Sold out | 0.00% | −1.86 |
| SMR Nuscale Power Corp. | Sold out | 0.00% | −1.48 |
| QURE Uniqure NV | Reduce -22.0% | 1.60% | −1.40 |
| SNOW Snowflake Inc. | Reduce -36.0% | 1.86% | −0.79 |
| MRK Merck & Co. Inc. | Reduce -43.4% | 0.96% | −0.69 |
| ASTS Ast Spacemobile Inc. | Sold out | 0.00% | −0.54 |
| MSFT Microsoft Corp. | Sold out | 0.00% | −0.48 |
| ROIV Roivant Sciences Ltd. | Reduce -41.1% | 0.33% | −0.25 |
| CPNG Coupang Inc. | Reduce -42.3% | 0.48% | −0.24 |
| MRNA Moderna Inc. | Reduce -8.4% | 0.56% | −0.23 |
| RARE Ultragenyx Pharmaceutical Inc. | Reduce -3.3% | 2.36% | −0.13 |
| MGTX Meiragtx Holdings PLC | Reduce -48.0% | 0.21% | −0.11 |
| FNV Franco-Nevada Corp. | Sold out | 0.00% | −0.08 |
| BSAC Banco Santander-Chile-ADR | Sold out | 0.00% | −0.06 |
| HCC Warrior Met Coal Inc. | Sold out | 0.00% | −0.05 |
| BTG B2GOLD Corp. | Sold out | 0.00% | −0.05 |
| AIG American International Group | Reduce -19.2% | 0.15% | +0.01 |
| KRYS Krystal Biotech Inc. | Reduce -18.8% | 0.35% | +0.02 |
| ZLAB Zai Lab Ltd.-ADR | Reduce -28.6% | 1.25% | +0.14 |
| AXSM Axsome Therapeutics Inc. | Reduce -15.3% | 1.60% | +0.40 |
| PLTR Palantir Technologies Inc. Class A | Reduce -2.7% | 7.98% | +1.57 |
Portfolio Buys Q4 2024 → Q1 2025
| SWTX Springworks Therapeutics Inc. | New | 1.43% | +1.43 |
| VRTX Vertex Pharmaceuticals Inc. | New | 1.05% | +1.05 |
| ARWR Arrowhead Pharmaceuticals Inc. | Add +65.3% | 2.09% | +0.45 |
| ALNY Alnylam Pharmaceuticals Inc. | New | 0.40% | +0.40 |
| IMVT Immunovant Inc. | New | 0.32% | +0.32 |
| URGN Urogen Pharma Ltd. | Add +288.6% | 0.31% | +0.24 |
| CRSP Crispr Therapeutics AG | Add +71.7% | 0.53% | +0.22 |
| ABEV Ambev SA-ADR | Add +23.3% | 0.49% | +0.21 |
| PFE Pfizer Inc. | Add +47.1% | 0.21% | +0.08 |
| VZLA Vizsla Silver Corp. | Add +65.2% | 0.11% | +0.07 |
| VAL Valaris Ltd. | Add +42.6% | 0.21% | +0.06 |
| NOV Nov Inc. | Add +16.0% | 0.20% | +0.05 |
| RNAM Avidity Biosciences Inc. | Add +8.2% | 0.27% | +0.05 |
| SA Seabridge Gold Inc. | Add +22.5% | 0.13% | +0.04 |
| NTLA Intellia Therapeutics Inc. | Add +111.9% | 0.11% | +0.03 |
| VYGR Voyager Therapeutics Inc. | New | 0.02% | +0.02 |
| NE Noble Corp. PLC | Add +35.7% | 0.09% | +0.01 |
| URNM Sprott Uranium Miners ETF | Add +17.9% | 0.10% | +0.01 |
| WVE Wave Life Sciences Ltd. | Add +29.0% | 0.24% | −0.01 |
| FATE Fate Therapeutics Inc. | Add +25.3% | 0.02% | −0.01 |
| AUTL Autolus Therapeutics PLC | Add +8.6% | 0.10% | −0.02 |
| IONS Ionis Pharmaceuticals Inc. | Add +0.3% | 2.10% | −0.03 |
| DYN Dyne Therapeutics Inc. | Add +35.4% | 0.08% | −0.03 |
| FDMT 4D Molecular Therapeutics Inc. | Add +8.3% | 0.11% | −0.04 |
| LXEO Lexeo Therapeutics Inc. | Add +16.0% | 0.14% | −0.06 |
| RCKT Rocket Pharmaceuticals Inc. | Add +8.8% | 0.75% | −0.39 |
Notes & Other Activity Q4 2024 → Q1 2025
| IONQ.WS Ionq Inc. -CW26 | *W EXP 09/30/202 | Sold out | 128,001 | $3.9Mbefore exit |
| CMPOW Composecure Inc. -CW25 | *W EXP 12/27/202 | Sold out | 148,853 | $692Kbefore exit |
| GCMGW GCM Grosvenor Inc. A -CW25 | *W EXP 11/17/202 | Sold out | 137,809 | $174Kbefore exit |
| GRND.WS Grindr Inc. -26 | *W EXP 11/18/202 | Sold out | 17,803 | $120Kbefore exit |
| IMTXW Immatics NV -CW | *W EXP 07/01/202 | Sold out | 267,725 | $67Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 61 | $544.2M | TSLA, SHOP, AMD, AMZN, IONS |
| Q1 2026 | 60 | $480.3M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q4 2025 | 57 | $543.1M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q3 2025 | 59 | $556.3M | TSLA, SPOT, SHOP, PLTR, AMZN |
| Q2 2025 | 55 | $463.5M | SPOT, TSLA, SHOP, PLTR, AMZN |
| Q1 2025 | 56 | $383.6M | SPOT, TSLA, SHOP, PLTR, SE |
| Q4 2024 | 59 | $437.0M | TSLA, SPOT, SHOP, AMZN, PLTR |
| Q3 2024 | 82 | $402.0M | TSLA, SPOT, SHOP, AMZN, ASTS |
| Q2 2024 | 85 | $358.2M | TSLA, SPOT, AMZN, SHOP, SNOW |
| Q1 2024 | 75 | $342.7M | SPOT, SHOP, TSLA, AMZN, SNOW |